Published in Proc Natl Acad Sci U S A on November 15, 1992
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12
Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol (1995) 3.66
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A (1993) 3.56
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A (1997) 3.31
Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects. Proc Natl Acad Sci U S A (2002) 3.06
A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci U S A (1993) 2.63
Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci (2001) 2.60
Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci U S A (1996) 2.12
Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc Natl Acad Sci U S A (1993) 1.87
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68
Molecular dynamics simulations of alanine rich beta-sheet oligomers: Insight into amyloid formation. Protein Sci (2002) 1.59
Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration. Proc Natl Acad Sci U S A (2001) 1.51
Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation. J Virol (1998) 1.49
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol (1998) 1.48
Protein engineering as a strategy to avoid formation of amyloid fibrils. Protein Sci (2000) 1.46
Amyloid peptide channels. J Membr Biol (2004) 1.43
Direct conversion of an oligopeptide from a beta-sheet to an alpha-helix: a model for amyloid formation. Proc Natl Acad Sci U S A (1997) 1.36
Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci U S A (1994) 1.35
Etiology and pathogenesis of prion diseases. Am J Pathol (1995) 1.35
Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc Natl Acad Sci U S A (1997) 1.34
Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc Natl Acad Sci U S A (1993) 1.31
Cooperative alpha-helix formation of beta-lactoglobulin and melittin induced by hexafluoroisopropanol. Protein Sci (1997) 1.28
Intersheet rearrangement of polypeptides during nucleation of {beta}-sheet aggregates. Proc Natl Acad Sci U S A (2005) 1.27
Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc Natl Acad Sci U S A (1995) 1.25
Solid-state NMR studies of the prion protein H1 fragment. Protein Sci (1996) 1.25
Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles? Acta Neuropathol (2014) 1.24
Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol (2000) 1.22
Genetic organization, length conservation, and evolution of RNA polymerase II carboxyl-terminal domain. Mol Biol Evol (2010) 1.20
Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses. Proc Natl Acad Sci U S A (1993) 1.08
Fibrillation of the major curli subunit CsgA under a wide range of conditions implies a robust design of aggregation. Biochemistry (2011) 1.05
Theoretical model of prion propagation: a misfolded protein induces misfolding. Proc Natl Acad Sci U S A (2005) 1.02
Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversion. PLoS One (2009) 1.01
Dynamic diagnosis of familial prion diseases supports the β2-α2 loop as a universal interference target. PLoS One (2011) 0.98
Conformational Properties of Helical Protein Polymers with Varying Densities of Chemically Reactive Groups. Macromolecules (2006) 0.97
Influence of pH on the human prion protein: insights into the early steps of misfolding. Biophys J (2010) 0.93
The stability and dynamics of the human calcitonin amyloid peptide DFNKF. Biophys J (2004) 0.92
Possible role of region 152-156 in the structural duality of a peptide fragment from sheep prion protein. Protein Sci (2004) 0.90
Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form. EMBO J (2001) 0.90
Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical. Biochem J (1999) 0.90
Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils. J Biol Chem (2011) 0.89
Structural instability of the prion protein upon M205S/R mutations revealed by molecular dynamics simulations. Biophys J (2006) 0.88
Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis (2012) 0.88
Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle. J Biol Chem (2012) 0.88
α-Cleavage of cellular prion protein. Prion (2012) 0.87
Characterization of the prion protein in human urine. J Biol Chem (2010) 0.86
Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP. Front Cell Dev Biol (2015) 0.85
Computer simulation study of amyloid fibril formation by palindromic sequences in prion peptides. Proteins (2011) 0.83
Prion protein misfolding. Curr Mol Med (2009) 0.82
Secondary structure provides a template for the folding of nearby polypeptides. Proc Natl Acad Sci U S A (2006) 0.82
Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein. Biophys J (2003) 0.81
Selenomethionine incorporation into amyloid sequences regulates fibrillogenesis and toxicity. PLoS One (2011) 0.81
Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides. Protein Sci (2003) 0.80
Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126. PLoS One (2013) 0.79
Probing the role of structural features of mouse PrP in yeast by expression as Sup35-PrP fusions. Prion (2012) 0.79
Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms. J Biol Chem (2012) 0.78
Design of metastable β-sheet oligomers from natively unstructured peptide. ACS Chem Neurosci (2013) 0.78
Prions, beta-sheets and transmissible dementias: is there still something missing? Acta Neuropathol (1995) 0.78
Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations. J Virol (2000) 0.78
Abnormalities in stress proteins in prion diseases. Cell Mol Neurobiol (1998) 0.78
Neurodegeneration in humans caused by prions. West J Med (1994) 0.77
Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. Biochem J (2000) 0.77
NMR structure and CD titration with metal cations of human prion alpha2-helix-related peptides. Bioinorg Chem Appl (2007) 0.77
β-hairpin-mediated formation of structurally distinct multimers of neurotoxic prion peptides. PLoS One (2014) 0.76
How do amino acid substitutions affect the amyloidogenic properties and seeding efficiency of prion peptides. Amino Acids (2013) 0.76
Solvent microenvironments and copper binding alters the conformation and toxicity of a prion fragment. PLoS One (2013) 0.75
Alpha-helix formation in melittin and beta-lactoglobulin A induced by fluorinated dialcohols. J Phys Chem B (2006) 0.75
Perceptions of prion disease. J Clin Pathol (1994) 0.75
Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates. PLoS Pathog (2017) 0.75
Predicted consequences of site-directed mutagenesis and the impact of species variation on prion protein misfolding through the N-terminal domain. J Mol Model (2005) 0.75
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol (1978) 33.47
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (1987) 17.08
Molecular biology of prion diseases. Science (1991) 10.83
A cellular gene encodes scrapie PrP 27-30 protein. Cell (1985) 8.86
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Purification and structural studies of a major scrapie prion protein. Cell (1984) 5.98
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry (1991) 5.53
Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A (1986) 4.38
The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem (1991) 4.23
N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol (1991) 3.55
Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol (1990) 3.46
Structure of a protein superfiber: spider dragline silk. Proc Natl Acad Sci U S A (1990) 3.37
Antibodies to a scrapie prion protein. Nature (1984) 3.09
Identification of prion amyloid filaments in scrapie-infected brain. Cell (1985) 3.04
Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology (1990) 2.90
Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem (1974) 2.69
Use of polylysine for adsorption of nuclei acids and enzymes to electron microscope specimen films. Proc Natl Acad Sci U S A (1977) 2.67
Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci U S A (1987) 2.61
Structure and X-ray amino acid sequence of a bacteriochlorophyll A protein from Prosthecochloris aestuarii refined at 1.9 A resolution. J Mol Biol (1986) 2.45
Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol (1990) 2.42
Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun (1989) 2.35
pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J (1991) 2.33
Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem (1990) 2.19
Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell (1992) 2.14
Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest (1991) 2.13
Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol (1986) 1.85
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J (1991) 1.74
Turn prediction in proteins using a pattern-matching approach. Biochemistry (1986) 1.65
Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. Biochemistry (1988) 1.57
Specific codon usage pattern and its implications on the secondary structure of silk fibroin mRNA. J Mol Biol (1988) 1.49
Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry (1990) 1.44
Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet (1992) 1.41
Interdomain motion in liver alcohol dehydrogenase. Structural and energetic analysis of the hinge bending mode. J Biol Chem (1986) 1.40
Molecular characteristics of prion rods purified from scrapie-infected hamster brains. J Infect Dis (1986) 1.37
The relation of the properties of Congo red-stained amyloid fibrils to the -conformation. J Histochem Cytochem (1972) 1.32
Adenovirus E4-dependent activation of the early E2 promoter is insufficient to promote the early-to-late-phase transition. J Virol (1991) 1.24
Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol (1992) 1.20
Human alpha 2(VI) collagen gene. Heterogeneity at the 5'-untranslated region generated by an alternate exon. J Biol Chem (1992) 1.15
Amyloid-like properties of a synthetic peptide corresponding to the carboxy terminus of beta-amyloid protein precursor. Arch Biochem Biophys (1992) 1.14
Alzheimer's disease: its proteins and genes. Cell (1988) 1.05
Predicted secondary structure and membrane topology of the scrapie prion protein. Protein Eng (1989) 1.02
AIDS virus and scrapie protein genes. Nature (1987) 0.84
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol (2000) 15.79
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet (1972) 9.01
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Identification of a protein that purifies with the scrapie prion. Science (1982) 7.00
A protease-resistant protein is a structural component of the scrapie prion. Cell (1983) 6.72
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet (1994) 6.50
Purification and structural studies of a major scrapie prion protein. Cell (1984) 5.98
Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 5.60
Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell (1995) 5.16
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15
Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell (1987) 5.12
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest (1987) 4.98
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell (1986) 4.82
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell (1989) 4.73
Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature (1989) 4.69
Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A (1986) 4.38
Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science (1990) 4.19
Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A (1997) 4.10
Further purification and characterization of scrapie prions. Biochemistry (1982) 4.01
Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A (1997) 3.78
A transmembrane form of the prion protein in neurodegenerative disease. Science (1998) 3.76
Redesigning trypsin: alteration of substrate specificity. Science (1985) 3.70
Linkage of prion protein and scrapie incubation time genes. Cell (1986) 3.69
Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol (1982) 3.68
Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A (1992) 3.68
Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol (1995) 3.66
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry (1993) 3.54
Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol (1990) 3.46
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Structural clues to prion replication. Science (1994) 3.43
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A (1999) 3.43
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A (1997) 3.42
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A (2001) 3.39
Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol (1988) 3.37
Evaluation of two enzyme-linked immunosorbent assays for the diagnosis of canine atopy. Vet Rec (1994) 3.23
Distinct prion proteins in short and long scrapie incubation period mice. Cell (1987) 3.21
Antibodies to a scrapie prion protein. Nature (1984) 3.09
Identification of prion amyloid filaments in scrapie-infected brain. Cell (1985) 3.04
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol (1997) 2.95
Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell (1993) 2.93
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol (1999) 2.92
Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology (1990) 2.90
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev (1992) 2.87
Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature (1999) 2.83
Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A (1996) 2.79
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature (2001) 2.78
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A (1994) 2.70
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell (1994) 2.68
Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem (1992) 2.67
Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci (1992) 2.67
Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest (1998) 2.64
Mapping the prion protein using recombinant antibodies. J Virol (1998) 2.64
Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci U S A (1987) 2.61
Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci (2001) 2.60
Scrapie prion proteins are synthesized in neurons. Am J Pathol (1986) 2.54
Splice junctions: association with variation in protein structure. Science (1983) 2.54
Pathologic conformations of prion proteins. Annu Rev Biochem (1998) 2.50
Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci U S A (1999) 2.44
The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity. Nat Struct Biol (1997) 2.44
Molecular cloning of a human prion protein cDNA. DNA (1986) 2.43
Prion protein gene variation among primates. J Mol Biol (1995) 2.43
Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol (1990) 2.42
Scrapie PrP 27-30 is a sialoglycoprotein. J Virol (1985) 2.40
Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev (1996) 2.39
Cultured cell sublines highly susceptible to prion infection. J Virol (2000) 2.38
Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci U S A (1994) 2.38
Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci U S A (1994) 2.37
Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem (1988) 2.35
Prion protein selectively binds copper(II) ions. Biochemistry (1998) 2.32
A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol (1997) 2.32
Changes in the localization of brain prion proteins during scrapie infection. Neurology (1987) 2.27
Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry (1980) 2.27
In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc Natl Acad Sci U S A (1999) 2.24
Uridine monophosphate kinase: A new genetic polymorphism with possible clinical implications. Am J Hum Genet (1974) 2.23
BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci (2000) 2.22
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology (2006) 2.21
Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med (2001) 2.21
Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker. J Biol Chem (2001) 2.18
Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury. Exp Neurol (2007) 2.18
Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell (1992) 2.14
Genetics and polymorphism of the mouse prion gene complex: control of scrapie incubation time. Mol Cell Biol (1988) 2.14
Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest (1991) 2.13
Monoclonal antibodies to the cellular and scrapie prion proteins. J Infect Dis (1986) 2.13
Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci U S A (1996) 2.12
Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol (1991) 2.11
Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet (1989) 2.11
Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci U S A (1993) 2.10
Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05
Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med (1999) 2.04
Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med (1985) 2.04
Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry (2000) 2.02